CASTLE BIOSCIENCES INC — Director's Dealing 2020

Dec 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-12-10

Reporting Person: Stokes Frank (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-10	Stock option (right to buy)	$59.16	A	31000	Acquired	2030-12-09	Common Stock (31000.0)	Direct
2020-12-10	Restricted Stock Units	$	A	8000	Acquired		Common Stock (8000.0)	Direct

Footnotes

F1: 25% of shares shall vest on December 10, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.

F2: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3: The RSUs vest in four equal annual installments beginning on December 10, 2021.